Medicines for four rare diseases become cheaper due to domestic production

Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news